Skip to main content
Premium Trial:

Request an Annual Quote

Cambridge Healthtech Institute, Wellcome Trust Sanger Institute

Premium
Cambridge Healthtech Institute’s Insight Pharma group has published “Next-Generation Sequencing: Scientific and Commercial Implications of the $1,000 Genome,” a market research report on next-generation sequencing technologies and their applications. The report covers technologies on the market or under development by Applied Biosystems, GE Healthcare, Helicos BioSciences, Illumina, Reveo, Roche/454 Life Sciences, VisiGen Biotechnologies, and others. It also includes the results of a survey of researchers at life science organizations involved with gene sequencing. 
 

 
The Wellcome Trust Sanger Institute’s Cancer Genome Project has released version 32 of the COSMIC (Catalog of Somatic Mutations in Cancer) database. COSMIC release 32 includes four new tumor suppressor genes and improved integration with the Ensembl genome browser. It includes information from 521,624 experiments, 235,207 tumors, 3,304 genes, and 445 fusions. 

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.